Cite
HARVARD Citation
Kadia, T. et al. (2018). Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trial. Lancet. 5 (9), pp. e411-e421. [Online].